Iovance Biotherapeutics Inc (IOVA) — Tangible Net Worth Ratio
Iovance Biotherapeutics Inc (IOVA) has a Tangible Net Worth Ratio of 59.4% as of September 2025. This metric is calculated by deducting intangible assets ($285.21 Million) from net assets ($702.29 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See IOVA current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Iovance Biotherapeutics Inc Tangible Net Worth Ratio (2008–2024)
This chart shows how Iovance Biotherapeutics Inc's Tangible Net Worth Ratio has changed across 14 annual periods from 2008 to 2024. As of September 2025, the ratio stands at 59.4%, reflecting net assets of $702.29 Million with intangible assets of $285.21 Million USD. See Iovance Biotherapeutics Inc liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Iovance Biotherapeutics Inc (2008–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Iovance Biotherapeutics Inc from 2008 to 2024, covering 14 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Iovance Biotherapeutics Inc stock valuation.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 60.2% | $710.40 Million | $282.40 Million | $910.43 Million | ▼ -0.5 pp |
| 2023 | 60.8% | $584.61 Million | $229.26 Million | $780.35 Million | ▼ -39.2 pp |
| 2022 | 100.0% | $499.64 Million | $0.00 | $663.98 Million | ▲ +0.0 pp |
| 2021 | 100.0% | $621.66 Million | $0.00 | $777.33 Million | ▲ +0.0 pp |
| 2020 | 100.0% | $656.50 Million | $0.00 | $768.46 Million | ▲ +0.0 pp |
| 2019 | 100.0% | $298.97 Million | $0.00 | $344.65 Million | ▲ +0.0 pp |
| 2018 | 100.0% | $466.19 Million | $0.00 | $480.82 Million | ▲ +0.0 pp |
| 2017 | 100.0% | $145.48 Million | $0.00 | $155.37 Million | ▲ +0.0 pp |
| 2016 | 100.0% | $166.92 Million | $0.00 | $171.89 Million | ▲ +0.0 pp |
| 2015 | 100.0% | $104.02 Million | $0.00 | $105.65 Million | ▲ +0.0 pp |
| 2014 | 100.0% | $44.85 Million | $0.00 | $46.51 Million | ▲ +0.0 pp |
| 2013 | 100.0% | $17.60 Million | $0.00 | $19.87 Million | ▲ +25.1 pp |
| 2010 | 74.9% | $638.09K | $160.04K | $1.46 Million | ▼ -25.1 pp |
| 2008 | 100.0% | $2.28K | $0.00 | $5.61K | — |